Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers

@article{Lheureux2006BenchtobedsideRH,
  title={Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers},
  author={Philippe E R Lheureux and Soheil Zahir and Mireille Gris and Anne-Sophie Derrey and Andr{\'e}a Penaloza},
  journal={Critical Care},
  year={2006},
  volume={10},
  pages={212 - 212}
}
Hyperinsulinaemia/euglycaemia therapy (HIET) consists of the infusion of high-dose regular insulin (usually 0.5 to 1 IU/kg per hour) combined with glucose to maintain euglycaemia. HIET has been proposed as an adjunctive approach in the management of overdose of calcium-channel blockers (CCBs). Indeed, experimental data and clinical experience, although limited, suggest that it could be superior to conventional pharmacological treatments including calcium salts, adrenaline (epinephrine) or… CONTINUE READING